BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3510255)

  • 1. Immunochemical analysis of the Ia polymorphisms among the family of DR7-associated HLA-D specificities.
    Karr RW
    J Immunol; 1986 Feb; 136(3):999-1006. PubMed ID: 3510255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cells homozygous for two HLA-DR7-associated HLA-D specificities express highly similar DR molecules but different DQ molecules.
    Karr RW; Hsu SH; Bias WB
    Hum Immunol; 1986 Feb; 15(2):198-210. PubMed ID: 3081469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
    Matsuyama T; Schwenzer J; Silver J; Winchester R
    J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
    Karr RW; Lipman LK; Alber C; Koning F; Goeken NE
    J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms within the HLA-DR4 haplotypes. Various DQ subtypes detected with monoclonal antibodies.
    Bontrop RE; Schreuder GM; Mikulski EM; van Miltenburg RT; Giphart MJ
    Tissue Antigens; 1986 Jan; 27(1):22-31. PubMed ID: 3006281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structural analysis of DR and DQ molecules among three HLA-D clusters associated with HLA-DR4].
    Ikeda H
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):898-907. PubMed ID: 2417927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
    Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
    J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
    Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
    J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary structural variation among serologically indistinguishable DS antigens: the MB3-bearing molecule in DR4 cells differs from the MB3-bearing molecule in DR5 cells.
    Giles RC; Hurley CK; Capra JD
    J Immunol; 1984 Jul; 133(1):1-3. PubMed ID: 6609970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of HLA-DRB and -DQB gene RFLPs in DR7 homozygous cell lines: associations with Dw11, Dw17 and DB1.
    Carlsson B; Wallin J
    Tissue Antigens; 1991 Feb; 37(2):74-8. PubMed ID: 1676192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
    Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
    J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants.
    MacLean GD; Seehafer J; Shaw AR; Kieran MW; Longenecker BM
    J Natl Cancer Inst; 1982 Aug; 69(2):357-64. PubMed ID: 6180206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical analysis of the polymorphism of three HLA-D region antigens.
    de Kretser T; Crumpton MJ; Bodmer JG; Bodmer WF
    Mol Biol Med; 1983 Jul; 1(1):59-76. PubMed ID: 6593560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant.
    Böhme J; Andersson M; Andersson G; Möller E; Peterson PA; Rask L
    J Immunol; 1985 Sep; 135(3):2149-55. PubMed ID: 2991381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of two distinct light chains in HLA-DR-associated antigens by two-dimensional gel electrophoresis.
    de Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
    Eur J Immunol; 1982 Mar; 12(3):214-21. PubMed ID: 6178597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.